Fact check: the mRNA Covid vaccines are causing immune system damage.
The Covid vaccines are causing a shift to igG4 immune response, a dangerous indication that the body is tolerating rather than fighting the virus.
Increased PD-L1 expression boosting causes cancer, repeated respiratory infections, destroys the immune system.
Your body sends out the protein PD-L1 in order to mitigate attacks against your own cells. PD-L1 suppression is a very effective modern cancer treatment, because it makes your T cells more likely to attack the cancers.
PD-L1 boosting by contrast basically destroys your body’s ability to fight cancers, respiratory infections, basically anything.
This recent study (Dec 2022) shows that the Covid vaccines boost PD-L1 expression.
https://pubmed.ncbi.nlm.nih.gov/36245120/
Normal PD-L1 expression is shown by the control group. The green error bars show PD-L1 expression post vaccination. A danger for increased incidence of cancer.
Indeed another paper written by a doctor Michel Goldman about his own experience with the booster exacerbating his lymphoma shows exactly this:
On the left is his lymphomas in a CT scan before the booster (black blobs), on the right afterwards.
https://www.frontiersin.org/articles/10.3389/fmed.2021.798095/full
The best article I have read on this topic is Arkmedic’s article:
Because of the vaccine booster shots, the body is beginning to tolerate the Spike Protein, treating it like an irritant, and this is leading to worsening outcomes.
New evidence from two new studies1 of strange immune system effects caused by the Covid mRNA vaccines; four common classes of antibodies are associated with immune response to viruses, antigens, and irritations such as pollen, igG1, 2, 3 and 4.
The first study, Conserved longitudinal alterations of anti-S-protein IgG subclasses in disease progression in initial ancestral Wuhan and vaccine breakthrough Delta infections, found that a larger igG3 response2 is associated with recovery, while a larger igG4 response is associated with progression of the disease.
igG4 response amplified, igG3 response muted. What does it mean?
Radagast says
After mRNA vaccination the immune response against Spike is shifting to IgG4, which is how your body responds after repeat exposure to stuff it needs to tolerate, like bee venom, pollen or peanut protein
Apparently, igG4 antibodies are the body’s immune response to repeated harmless annoyances, such as pollen or dust; and igG4 mutes the body’s inflammatory long term response. By contrast igG3 is a large part of the body’s response to viruses and causes an inflammatory response to a virus.
The Covid vaccine, by the third shot, is causing a muted igG3 response and an enhanced igG4 response to the SARS-CoV2 virus. This is associated with disease progression in Goh et al.
This means there may be many virus particles, but no appropriate immune response, and clinically speaking, the disease worsens.
Therefore, it would appear the Covid vaccines are turning people into asymptomatic carriers, with a large viral load and a muted inflammatory response to the virus. Not only that, Radagast, writing on Rintrah, claims they are more at risk of death because of the inappropriate immune response.
Radagast explains what it means:
IgG3 is an antibody that carries out 42.2% of the neutralisation when the body is fighting the SARS-CoV2 virus, according to Kober, Manni et al “IgG3 and IgM Identified as Key to SARS-CoV-2 Neutralization”
What you want to see, what you normally would see, after a covid infection, is this:
On the left you see who does the neutralization, right you see what percentage of total antibodies they are. Despite being just 3% of your antibody mass, IgG3 is carrying out 42.2% of the neutralization.
IgA is busy in mucus dealing with this virus, IgM responds to the infection by bringing the viral load down, IgG3 then joins the fight and tags any remaining hide-outs this virus has, so that your body doesn’t end up tolerating this nasty sarbecovirus in the background.
If it wasn’t obvious yet, for whatever reason our bodies do seem to be tolerating the spread of this virus through our population. Look at what’s happening to my poor little country:
The captions at the top say,
The average number of virus particles over time
This graph shows the average number of virus particles per 100,000 inhabitants over time
Here is what is happening now - note particularly those who had a breakthrough infection, with the asterisks. They are showing elevated igG4 levels.
Radagast notes that the deaths from Covid are rising also, at least in the Netherlands, where he lives.
IgG4 Off the charts
IgG4 response according to Arkmedic’s analysis is off the charts in mRNA vaccine recipients; he shows how the FDA VRBPAC submission chart of 10th Dec 2020 actually minimises the difference by displaying it in a logarithmic scale- the chart on the right is a more realistic representation.
Hat tip to Igor Chudov. Igor’s article is well worth reading.
This article will be added to my previous fact check of this subject.
Gerling, Kocher, Lapuente, Steininger, Habenicht, Wytopil, Beileke, Schäfer, Tenbusch et al. Class switch towards non-inflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination Irrgang, Science Immunology 22 Dec 2022 First Release DOI: 10.1126/sciimmunol.ade2798 https://www.science.org/doi/10.1126/sciimmunol.ade2798
and
Goh YS, Fong SW, Hor PX, Amrun SN, Lee CY, Young BE, Chia PY, Tambyah PA, Kalimuddin S, Pada S, Tan SY, Sun LJ, Chen MI, Leo YS, Lye DC, Ng LFP, Renia L. Conserved longitudinal alterations of anti-S-protein IgG subclasses in disease progression in initial ancestral Wuhan and vaccine breakthrough Delta infections. Front Microbiol. 2022 Nov 22;13:1043049. doi: 10.3389/fmicb.2022.1043049. PMID: 36483199; PMCID: PMC9723332. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723332/#SM1
To be more precise they found that a greater ratio of igG1 & igG3 response compared to igG2 and igG4, is associated with recovery from the disease. A greater ratio of igG2 & igG4 response is associated with disease progression.